G100
3475-174
Phase 2 small_molecule terminated
Quick answer
G100 for Follicular Low Grade Non-Hodgkin's Lymphoma is a Phase 2 program (small_molecule) at Design Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Design Therapeutics
- Indication
- Follicular Low Grade Non-Hodgkin's Lymphoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated